• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human 3-oxo-5-alpha-steroid 4-dehydrogenase 2 (SRD5A2), Truncated

ACP01481

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01481 Target NameSRD5A2
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range29-71aaMol Weight20.0 kDa
Protein LengthPartialPurityGreater than 85% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP31213
Background Information
  • Uniprot Id

    P31213

  • Target Species

    Human

  • Target Name

    SRD5A2

  • Target Full Name

    3-oxo-5-alpha-steroid 4-dehydrogenase 2

  • Target Function

    Converts testosterone (T) into 5-alpha-dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology.

  • Target Involvement

    Pseudovaginal perineoscrotal hypospadias (PPSH)

  • Target Subcellular Location

    Microsome membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein.

  • Target Protein Families

    Steroid 5-alpha reductase family

  • Target Tissue Specificity

    Expressed in high levels in the prostate and many other androgen-sensitive tissues.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    SRD5A2; 3-oxo-5-alpha-steroid 4-dehydrogenase 2; 5 alpha-SR2; SR type 2; Steroid 5-alpha-reductase 2; S5AR 2; Type II 5-alpha reductase

Inquire Recombinant Human 3-oxo-5-alpha-steroid 4-dehydrogenase 2 (SRD5A2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification